TNF and neoplasm: Despite the fact that TRAIL, TNFα and Fas share common pro-apoptotic partners and modalities, only TRAIL displays tumour selective pro-apoptotic activity, sparing normal tissues or cells [237,244], including when administered to small animals or humans [243].